Cargando…
Metronomic capecitabine inhibits liver transplant rejection in rats by triggering recipients’ T cell ferroptosis
BACKGROUND: Capecitabine (CAP) is a classic antimetabolic drug and has shown potential antirejection effects after liver transplantation (LT) in clinical studies. Our previous study showed that metronomic CAP can cause the programmed death of T cells by inducing oxidative stress in healthy mice. Fer...
Autores principales: | Wang, Hao, Wang, Zheng-Lu, Zhang, Sai, Kong, De-Jun, Yang, Rui-Ning, Cao, Lei, Wang, Jian-Xi, Yoshida, Sei, Song, Zhuo-Lun, Liu, Tao, Fan, Shun-Li, Ren, Jia-Shu, Li, Jiang-Hong, Shen, Zhong-Yang, Zheng, Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10280797/ https://www.ncbi.nlm.nih.gov/pubmed/37346150 http://dx.doi.org/10.3748/wjg.v29.i20.3084 |
Ejemplares similares
-
Durable effect of imatinib and metronomic chemotherapy with capecitabine in pancreatic carcinoma
por: Al-Sukhun, Sana, et al.
Publicado: (2023) -
Detection of Donor-Derived Microparticles in the Peripheral Blood of a Hand Transplant Recipient During Rejection
por: Kim, Joseph Y., et al.
Publicado: (2017) -
Effect of CXCR3/HO-1 genes modified bone marrow mesenchymal stem cells on small bowel transplant rejection
por: Yin, Ming-Li, et al.
Publicado: (2017) -
Metronomic chemotherapy with capecitabine for metastatic colorectal cancer in very elderly patients
por: Jung, Yun Hwa, et al.
Publicado: (2017) -
Cost-effectiveness analysis of metronomic capecitabine as adjuvant chemotherapy in locoregionally advanced nasopharyngeal carcinoma
por: She, Longjiang, et al.
Publicado: (2022)